Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies
Abstract Introduction Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA). This post hoc analysis assessed the efficacy of tofacitinib using pooled data from two phase 3 studies of patients with active PsA. Methods Data were pooled from OPAL Broaden (NCT01877...
Asıl Yazarlar: | , , , , , , , , , , |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
Adis, Springer Healthcare
2018-11-01
|
Seri Bilgileri: | Rheumatology and Therapy |
Konular: | |
Online Erişim: | http://link.springer.com/article/10.1007/s40744-018-0131-5 |